Cambrex to Present at Upcoming Investor Conferences in September
August 30 2017 - 9:15AM
Cambrex Corporation (NYSE:CBM), a leading manufacturer of small
molecule innovator and generic Active Pharmaceutical Ingredients
(APIs), today announced that company management will present at the
following investor conferences in September:
2017 Wells Fargo Healthcare
ConferenceDate: Wednesday,
September 6, 2017Time: 4:10 p.m.
EDTLocation: Boston, MA
Baird’s 2017 Global Healthcare
ConferenceDate: Thursday, September
7, 2017Time: 10:15 a.m.
EDTLocation: New York, NY
The live audio webcasts and slide presentations can be accessed
from the Cambrex website at www.cambrex.com in the Investors
section under “Webcasts & Presentations”, and replays will be
available for 90 days after the live events conclude.
About
Cambrex Cambrex Corporation is an innovative
life sciences company that provides products, services and
technologies to accelerate the development and commercialization of
small molecule therapeutics. The Company offers Active
Pharmaceutical Ingredients (APIs), advanced intermediates and
enhanced drug delivery products for branded and generic
pharmaceuticals. Development and manufacturing capabilities include
enzymatic biotransformations, high potency APIs, high energy
chemical synthesis and controlled substances. For more
information, please visit www.cambrex.com.
Contact:
Stephanie LaFiura
Investor Relations Associate
Tel: 201.804.3037
Email: stephanie.lafiura@cambrex.com
Cambrex (NYSE:CBM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cambrex (NYSE:CBM)
Historical Stock Chart
From Apr 2023 to Apr 2024